Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Chromosome analysis; additional cells counted, each study

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 88285 refers to a laboratory procedure specifically designed for chromosome analysis, focusing on the counting of additional cells during the study. This analysis is crucial in various medical contexts, as it helps in identifying chromosomal abnormalities that may be present in a sample. The procedure can be conducted on various biological specimens, including blood, bone marrow, solid tissues, amniotic fluid, and chorionic villi. The process begins with the collection of cells, which are then cultured to promote growth. Following this, the cells undergo a meticulous counting and sorting process. The standard protocol requires a minimum of 20 cells to be counted, with at least 5 cells and 2 karyotypes analyzed to ensure a comprehensive evaluation. In cases where structural aberrations are detected, particularly in instances of mosaicism, additional cell counts may be necessary to reach a definitive diagnosis. The use of code 88285 is specifically designated for each additional cell count study performed, highlighting its importance in the overall assessment of chromosomal integrity and abnormalities.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 88285 is indicated for various clinical scenarios where chromosome analysis is necessary. The following conditions may warrant this analysis:

  • Chromosomal Abnormalities The test is performed to investigate suspected chromosomal abnormalities that may be present in a patient’s sample.
  • Mosaicism When structural aberrations are observed in some cells, indicating the presence of mosaicism, additional cell counts may be required for accurate diagnosis.
  • Genetic Disorders The analysis is utilized in the evaluation of genetic disorders that may be linked to chromosomal irregularities.
  • Pre-Natal Testing The procedure can be indicated in pre-natal testing scenarios, such as analyzing amniotic fluid or chorionic villi for potential chromosomal issues.

2. Procedure

The procedure for chromosome analysis under CPT® Code 88285 involves several critical steps to ensure accurate results. The following outlines the procedural steps:

  • Cell Collection Initially, a sample is collected from the patient, which may include blood, bone marrow, solid tissue, amniotic fluid, or chorionic villi. This step is crucial as the quality and type of sample can significantly impact the analysis.
  • Cell Culturing Once the sample is obtained, the cells are cultured in a laboratory setting. This process allows the cells to grow and multiply, providing a sufficient number of cells for analysis.
  • Cell Counting and Sorting After culturing, the cells are meticulously counted and sorted. The standard procedure requires a minimum of 20 cells to be counted, with at least 5 cells and 2 karyotypes analyzed to ensure a thorough examination.
  • Additional Cell Counts If structural aberrations are detected in some cells, particularly in cases of mosaicism, additional cell counts may be performed. This step is essential for confirming the presence of chromosomal abnormalities and aiding in diagnosis.

3. Post-Procedure

Following the chromosome analysis procedure, there are several considerations for post-procedure care and expected outcomes. Patients may need to be monitored for any immediate reactions to the sample collection, especially if blood or bone marrow was used. The results of the chromosome analysis will typically be reviewed and interpreted by a qualified geneticist or pathologist, who will provide a detailed report. This report may include findings related to chromosomal structure and any abnormalities detected. Depending on the results, further testing or follow-up consultations may be necessary to discuss implications for the patient’s health or potential genetic counseling options.

Short Descr CHROMOSOME COUNT ADDITIONAL
Medium Descr CHRMSM ANALYSIS ADDL CELLS COUNTED EACH STUDY
Long Descr Chromosome analysis; additional cells counted, each study
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 10
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GC This service has been performed in part by a resident under the direction of a teaching physician
GZ Item or service expected to be denied as not reasonable and necessary
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
Q4 Service for ordering/referring physician qualifies as a service exemption
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
Date
Action
Notes
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"